share_log

This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan

This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan

随着软银计划在日本推出人工智能医疗服务,这家人工智能股票在盘前涨近3%
Benzinga ·  06/26 06:42

SoftBank Group (OTC:SFTBY) (OTC:SFTBF) is set to introduce a medical service in Japan that uses artificial intelligence to analyze personal medical data, including genetic information. The service will be launched through a joint venture with U.S. healthcare company Tempus AI Inc. (NASDAQ:TEM). Following the report, Tempus AI Inc.'s stock surged nearly 3% in pre-market hours trading.

SoftBank Group (场外交易:SFTBY) (场外交易:SFTBF)将会在日本推出一项医疗服务,该服务使用人工智能分析个人医疗数据,包括基因信息。该服务将通过与美国医疗保健公司Tempus AI Inc.(纳斯达克:TEM)的合资企业的联合推出。据Nikkei周二报道,该服务预计将于7月份开始营运,计划在一至两年内开始提供服务。此消息发布后,Tempus AI股价在盘前交易中上涨了近3%。

What Happened: The joint venture, capitalized at 30 billion yen ($188 million), will be equally owned by SoftBank Group and Tempus AI. The venture is expected to commence operations as early as July and aims to start providing services within one to two years, reported Nikkei on Tuesday.

发生了什么: 这家总资本为300亿日元(1.88亿美元)的合资企业将由SoftBank Group和Tempus AI平分股权。据《Nikkei》周二报道,合资企业预计将于7月份开始运作,并计划在一至两年内开始提供服务。

Tempus AI, through its analytical machine learning platform, enables physicians to make real-time, data-driven decisions to provide personalized care and targeted therapies for patients using the power of AI in healthcare.

通过其分析机器学习平台,Tempus AI可以使医生作出实时、数据驱动的决策,为患者提供个性化护理和有针对性的治疗,利用人工智能在医疗保健领域的能力。

SoftBank and Tempus AI did not immediately respond to Benzinga's request for comment.

SoftBank和Tempus AI还未对Benzinga的置评请求做出回应。

Why It Matters: This initiative comes at a crucial time for SoftBank, which has faced significant challenges in recent years. In 2019, SoftBank's Vision Fund sold all of its shares in Nvidia, missing out on a potential gain of over $150 billion.

为什么它很重要: 此举对SoftBank来说是在一个关键时刻,该公司在最近几年面临了重大挑战。2019年,SoftBank的Vision Fund出售了其在英伟达的所有股票,错失了逾1500亿美元的潜在收益。

Moreover, Masayoshi Son has seen a notable drop in shareholder support for his reappointment as CEO, falling from 95.93% to 79.22% in a year, following a recommendation by proxy advisor Institutional Shareholder Services.

此外,孙正义在股东支持其连任CEO方面出现了明显下降,经过股权代理机构Institutional Shareholder Services的建议,支持度从95.93%下降到79.22%。

In addition, activist investor Elliott Investment Management has taken a $2 billion stake in SoftBank and is demanding a $15 billion share buyback, reflecting investor concerns over the company's strategic direction.

此外,激进投资者Elliott Investment Management已经获得了价值20亿美元的SoftBank股份,并要求进行150亿美元的股票回购,反映了投资者对该公司战略方向的担忧。

Finally, the collaboration between SoftBank and Tempus AI aligns with a broader trend of integrating AI into healthcare. For instance, Microsoft-backed OpenAI has partnered with Color Health to develop AI-driven cancer care solutions.

最后,SoftBank与Tempus AI之间的合作符合将人工智能与医疗保健业务整合的趋势。例如Microsoft支持的OpenAI已经与Color Health合作开发了基于人工智能的癌症治疗解决方案。Microsoft-b价格走势: Tempus AI Inc.周二收盘价为24.96美元,当日下跌了1.38%。在盘前交易中,该股上涨了2.52%。根据Benzinga Pro的数据,自公开上市以来,Tempus AI Inc.的股价已经下跌了37.99%。

Price Action: Tempus AI Inc. closed at $24.96 on Tuesday, experiencing a decrease of 1.38% for the day. In pre-market trading, the stock rose by 2.52%. Since its public debut, Tempus AI Inc. has seen a decline of 37.99%, according to data from Benzinga Pro.

价格行动:Tempus AI公司周二收盘价为24.96美元,当天下跌1.38%。在美股盘前交易中,该股票上涨了2.52%。根据Benzinga Pro的数据,Tempus AI公司自上市以来已经下跌了37.99%。

Image Via Shutterstock

图片来自Shutterstock。

This story was generated using Benzinga Neuro and edited by Kaustubh Bagalkote

本报道使用Benzinga Neuro生成,并由Kaustubh Bagalkote

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发